Article
Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer.
Cancer research - 1 Oct 2014
Geng Chuandong, Rajapakshe Kimal, Shah Shrijal S, Shou John, Eedunuri Vijay Kumar, Foley Christopher, Fiskus Warren, Rajendran Mahitha, Chew Sue Anne, Zimmermann Martin, Bond Richard, He Bin, Coarfa Cristian, Mitsiades Nicholas
Abstract excerpt
Somatic missense mutations in the substrate-binding pocket of the E3 ubiquitin ligase adaptor SPOP are present in up to 15% of human prostate adenocarcinomas, but are rare in other malignancies, suggesting a prostate-specific mechanism of action. SPOP promotes ubiquitination and degradation of several protein substrates, including the androgen receptor (AR) coactivator SRC-3. However, the relative contributions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
